General Information of This Antigen (ID: TAR0MSWGX)
Antigen Name
Tumor necrosis factor (TNF)
Gene Name
TNF
Gene ID
7124
Synonym
TNFA; TNFSF2; Cachectin;TNF-alpha;Tumor necrosis factor ligand superfamily member 2
Sequence
MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQR
EEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELR
DNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRE
TPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL

    Click to Show/Hide
Family
Tumor necrosis factor family
Function
Cytokine that binds to TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. It is mainly secreted by macrophages and can induce cell death of certain tumor cell lines. It is potent pyrogen causing fever by direct action or by stimulation of interleukin-1 secretion and is implicated in the induction of cachexia, Under certain conditions it can stimulate cell proliferation and induce cell differentiation. Impairs regulatory T- cells (Treg) function in individuals with rheumatoid arthritis via FOXP3 dephosphorylation. Up-regulates the expression of protein phosphatase 1 (PP1), which dephosphorylates the key 'Ser-418' residue of FOXP3, thereby inactivating FOXP3 and rendering Treg cells functionally defective. Key mediator of cell death in the anticancer action of BCG-stimulated neutrophils in combination with DIABLO/SMAC mimetic in the RT4v6 bladder cancer cell line. Induces insulin resistance in adipocytes via inhibition of insulin-induced IRS1 tyrosine phosphorylation and insulin-induced glucose uptake. Induces GKAP42 protein degradation in adipocytes which is partially responsible for TNF-induced insulin resistance. Plays a role in angiogenesis by inducing VEGF production synergistically with IL1B and IL6.

    Click to Show/Hide
Uniprot Entry
TNFA_HUMAN
HGNC ID
HGNC:11892
KEGG ID
hsa:7124
Each Antibody-drug Conjugate and Its Component Related to This Antigen
Full List of The ADC Related to This Antigen
The Numbers of ADCs, Their Three Components, Payload Targets, and Corresponding Diseases for This Antigens
Adalimumab
ADC Name Payload Target Linker ADC Info
ABBV-3373
Glucocorticoid receptor modulator
Glucocorticoid receptor (NR3C1)
MP-Ala-Ala
ABBV-154
Glucocorticoid receptor modulator
Glucocorticoid receptor (NR3C1)
Formyl-Gly-Glu
Adalimumab/anti-Ang2 Zybody [1]
Angiopep-2 TFA
Undisclosed
Undisclosed
Adalimumab fosimdesonide [2]
SGD-1882
Human Deoxyribonucleic acid (hDNA)
Undisclosed
WO2022171101A1 ADC-45 [3]
WO2022171101A1 ADC-45 payload
Undisclosed
WO2022171101A1 ADC-45 linker
WO2022171101A1 ADC-48 [3]
WO2022171101A1 ADC-48 payload
Undisclosed
WO2022171101A1 ADC-48 linker
WO2023025248A1 ADC-56 [4]
WO2023025248A1 ADC-56 payload
Undisclosed
WO2023025248A1 ADC-56 linker
WO2022135332A1 1-9 [5]
WO2022135332A1_1-9 payload
Undisclosed
WO2022135332A1_1-9 linker
WO2022135332A1 1-10 [5]
WO2022135332A1_1-10 payload
Undisclosed
WO2022135332A1_1-10 linker
WO2022135332A1 1-11 [5]
WO2022135332A1_1-11 payload
Undisclosed
WO2022135332A1_1-11 linker
WO2022135332A1 1-13 [5]
WO2022135332A1_1-13 payload
Undisclosed
WO2022135332A1_1-13 linker
Adalimumab-Compound 9 [6]
Mertansine DM1
Microtubule (MT)
Adalimumab-Compound 9 linker
Adalimumab-Compound 17 [6]
Mertansine DM4
Microtubule (MT)
Adalimumab-Compound 17 linker
Adalimumab-Compound 25 [6]
Monomethyl auristatin E
Microtubule (MT)
Adalimumab-Compound 25 linker
Adalimumab-Compound 31 [6]
Auristatin 0101
Microtubule (MT)
Adalimumab-Compound 31 linker
Adalimumab-Compound 36 [6]
Monomethyl auristatin E
Microtubule (MT)
Adalimumab-Compound 36 linker
Adalimumab-Compound 43 [6]
PBD dimer
Human Deoxyribonucleic acid (hDNA)
Adalimumab-Compound 43 linker
Adalimumab-Compound 49 [6]
PBD dimer
Human Deoxyribonucleic acid (hDNA)
Adalimumab-Compound 49 linker
Adalimumab-Compound 55 [6]
Mertansine DM1
Microtubule (MT)
Adalimumab-Compound 55 linker
Adalimumab-Compound 59 [6]
Mertansine DM4
Microtubule (MT)
Adalimumab-Compound 59 linker
Adalimumab-Compound 64 [6]
Monomethyl auristatin E
Microtubule (MT)
Adalimumab-Compound 64 linker
Adalimumab-Compound 69 [6]
Monomethyl auristatin E
Microtubule (MT)
Adalimumab-Compound 69 linker
Adalimumab-Compound 74 [6]
PBD dimer
Human Deoxyribonucleic acid (hDNA)
Adalimumab-Compound 74 linker
Adalimumab-Compound 75 [6]
Monomethyl auristatin E
Microtubule (MT)
Adalimumab-Compound 75 linker
Adalimumab-Compound 76 [6]
Monomethyl auristatin E
Microtubule (MT)
Adalimumab-Compound 76 linker
Adalimumab-Compound 77 [6]
Mertansine DM1
Microtubule (MT)
Adalimumab-Compound 77 linker
Adalimumab-Compound 78 [6]
Auristatin 0101
Microtubule (MT)
Adalimumab-Compound 78 linker
Adalimumab-Compound 79 [6]
Auristatin 0101
Microtubule (MT)
Adalimumab-Compound 79 linker
Adalimumab-Compound 80 [6]
Mertansine DM4
Microtubule (MT)
Adalimumab-Compound 80 linker
Anti-TNFalpha_VCGP-Dex [7]
Dexamethasone
Glucocorticoid receptor (NR3C1)
Mal-ValCitGlyPro-OH
Golimumab
ADC Name Payload Target Linker ADC Info
Golimumab-Compound 9 [6]
Mertansine DM1
Microtubule (MT)
Golimumab-Compound 9 linker
Golimumab-Compound 17 [6]
Mertansine DM4
Microtubule (MT)
Golimumab-Compound 17 linker
Golimumab-Compound 25 [6]
Monomethyl auristatin E
Microtubule (MT)
Golimumab-Compound 25 linker
Golimumab-Compound 31 [6]
Auristatin 0101
Microtubule (MT)
Golimumab-Compound 31 linker
Golimumab-Compound 36 [6]
Monomethyl auristatin E
Microtubule (MT)
Golimumab-Compound 36 linker
Golimumab-Compound 43 [6]
PBD dimer
Human Deoxyribonucleic acid (hDNA)
Golimumab-Compound 43 linker
Golimumab-Compound 49 [6]
PBD dimer
Human Deoxyribonucleic acid (hDNA)
Golimumab-Compound 49 linker
Golimumab-Compound 55 [6]
Mertansine DM1
Microtubule (MT)
Golimumab-Compound 55 linker
Golimumab-Compound 59 [6]
Mertansine DM4
Microtubule (MT)
Golimumab-Compound 59 linker
Golimumab-Compound 64 [6]
Monomethyl auristatin E
Microtubule (MT)
Golimumab-Compound 64 linker
Golimumab-Compound 69 [6]
Monomethyl auristatin E
Microtubule (MT)
Golimumab-Compound 69 linker
Golimumab-Compound 74 [6]
PBD dimer
Human Deoxyribonucleic acid (hDNA)
Golimumab-Compound 74 linker
Golimumab-Compound 75 [6]
Monomethyl auristatin E
Microtubule (MT)
Golimumab-Compound 75 linker
Golimumab-Compound 76 [6]
Monomethyl auristatin E
Microtubule (MT)
Golimumab-Compound 76 linker
Golimumab-Compound 77 [6]
Mertansine DM1
Microtubule (MT)
Golimumab-Compound 77 linker
Golimumab-Compound 78 [6]
Auristatin 0101
Microtubule (MT)
Golimumab-Compound 78 linker
Golimumab-Compound 79 [6]
Auristatin 0101
Microtubule (MT)
Golimumab-Compound 79 linker
Golimumab-Compound 80 [6]
Mertansine DM4
Microtubule (MT)
Golimumab-Compound 80 linker
ADC Name Payload Target Linker ADC Info
38780432 ADC 8 [8]
Cpd 6
Undisclosed
BrAc-Ala-Ala
Human anti-TNF
ADC Name Payload Target Linker ADC Info
37379257 ADC 5 [9]
Undisclosed
Undisclosed
MP-Ala-Ala
37379257 ADC 6 [9]
Undisclosed
Undisclosed
M-Gly-Ala-Ala
37379257 ADC 17 [9]
Undisclosed
Undisclosed
M-Gly-Ala-Ala
37379257 ADC 18 [9]
Undisclosed
Undisclosed
M-Gly-Ala
37379257 ADC 19 [9]
Undisclosed
Undisclosed
M-Gly-GluF
Infliximab
ADC Name Payload Target Linker ADC Info
Infliximab-Compound 9 [6]
Mertansine DM1
Microtubule (MT)
Infliximab-Compound 9 linker
Infliximab-Compound 17 [6]
Mertansine DM4
Microtubule (MT)
Infliximab-Compound 17 linker
Infliximab-Compound 25 [6]
Monomethyl auristatin E
Microtubule (MT)
Infliximab-Compound 25 linker
Infliximab-Compound 31 [6]
Auristatin 0101
Microtubule (MT)
Infliximab-Compound 31 linker
Infliximab-Compound 36 [6]
Monomethyl auristatin E
Microtubule (MT)
Infliximab-Compound 36 linker
Infliximab-Compound 43 [6]
PBD dimer
Human Deoxyribonucleic acid (hDNA)
Infliximab-Compound 43 linker
Infliximab-Compound 49 [6]
PBD dimer
Human Deoxyribonucleic acid (hDNA)
Infliximab-Compound 49 linker
Infliximab-Compound 55 [6]
Mertansine DM1
Microtubule (MT)
Infliximab-Compound 55 linker
Infliximab-Compound 59 [6]
Mertansine DM4
Microtubule (MT)
Infliximab-Compound 59 linker
Infliximab-Compound 64 [6]
Monomethyl auristatin E
Microtubule (MT)
Infliximab-Compound 64 linker
Infliximab-Compound 69 [6]
Monomethyl auristatin E
Microtubule (MT)
Infliximab-Compound 69 linker
Infliximab-Compound 74 [6]
PBD dimer
Human Deoxyribonucleic acid (hDNA)
Infliximab-Compound 74 linker
Infliximab-Compound 75 [6]
Monomethyl auristatin E
Microtubule (MT)
Infliximab-Compound 75 linker
Infliximab-Compound 76 [6]
Monomethyl auristatin E
Microtubule (MT)
Infliximab-Compound 76 linker
Infliximab-Compound 77 [6]
Mertansine DM1
Microtubule (MT)
Infliximab-Compound 77 linker
Infliximab-Compound 78 [6]
Auristatin 0101
Microtubule (MT)
Infliximab-Compound 78 linker
Infliximab-Compound 79 [6]
Auristatin 0101
Microtubule (MT)
Infliximab-Compound 79 linker
Infliximab-Compound 80 [6]
Mertansine DM4
Microtubule (MT)
Infliximab-Compound 80 linker
ADC Name Payload Target Linker ADC Info
WO2024140927A1-ADC-C (DAR2) [10]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
WO2024140927A1-ADC-C (DAR4) [10]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
WO2024140927A1-ADC-C (DAR7) [10]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Mouse anti-TNF
ADC Name Payload Target Linker ADC Info
37379257 ADC 3 [9]
Undisclosed
Undisclosed
MP-Ala-Ala
37379257 ADC 4 [9]
Undisclosed
Undisclosed
M-Gly-Ala-Ala
37379257 ADC 14 [9]
Undisclosed
Undisclosed
M-Gly-Ala-Ala
37379257 ADC 15 [9]
Undisclosed
Undisclosed
M-Gly-Ala
37379257 ADC 16 [9]
Undisclosed
Undisclosed
M-Gly-GluF
ADC Name Payload Target Linker ADC Info
38780432 ADC 1 [8]
Cpd 2
Undisclosed
MP-Ala-Ala
38780432 ADC 2 [8]
Cpd 6
Undisclosed
M-Gly-GluF
38780432 ADC 3 [8]
Cpd 4
Undisclosed
M-Gly-GluF
38780432 ADC 4 [8]
Cpd 6
Undisclosed
M-Gly-Ala-Ala
38780432 ADC 5 [8]
Cpd 6
Undisclosed
BrAc-Ala-Ala
38780432 ADC 6 [8]
Cpd 6
Undisclosed
BrAc-Gly-Glu
38780432 ADC 7 [8]
Cpd 6
Undisclosed
BrAc-Ala-Glu
Undisclosed
ADC Name Payload Target Linker ADC Info
38283215 ADC 1 [11]
GRM payload C1
Undisclosed
Ala-Ala linker
38283215 ADC 2 [11]
GRM payload C1
Undisclosed
Ala-Arg linker
38283215 ADC 3 [11]
GRM payload C1
Undisclosed
Ala-Gln linker
38283215 ADC 4 [11]
GRM payload C1
Undisclosed
Ala-Glu linker
38283215 ADC 5 [11]
GRM payload C1
Undisclosed
Ala-Gly linker
38283215 ADC 6 [11]
GRM payload C1
Undisclosed
Ala-His linker
38283215 ADC 7 [11]
GRM payload C1
Undisclosed
Ala-Lys linker
38283215 ADC 8 [11]
GRM payload C1
Undisclosed
Ala-Ser linker
38283215 ADC 9 [11]
GRM payload C1
Undisclosed
Gly-Ala linker
38283215 ADC 10 [11]
GRM payload C1
Undisclosed
Gly-Gln linker
38283215 ADC 11 [11]
GRM payload C1
Undisclosed
Gly-Glu linker
38283215 ADC 12 [11]
GRM payload C1
Undisclosed
Gly-Gly linker
38283215 ADC 13 [11]
GRM payload C1
Undisclosed
Gly-Ser linker
38283215 ADC 14 [11]
GRM payload C1
Undisclosed
Phe-Lys linker
38283215 ADC 15 [11]
GRM payload C1
Undisclosed
Ser-Ala linker
38283215 ADC 16 [11]
GRM payload C1
Undisclosed
Ser-Asn linker
38283215 ADC 17 [11]
GRM payload C1
Undisclosed
Ser-Gln linker
38283215 ADC 18 [11]
GRM payload C1
Undisclosed
Ser-Glu linker
38283215 ADC 19 [11]
GRM payload C1
Undisclosed
Ser-Gly linker
38283215 ADC 20 [11]
GRM payload C1
Undisclosed
Val-Ala linker
38283215 ADC 21 [11]
GRM payload C1
Undisclosed
Val-Arg linker
38283215 ADC 22 [11]
GRM payload C1
Undisclosed
Val-Cit linker
38283215 ADC 23 [11]
GRM payload C1
Undisclosed
Val-Asn linker
38283215 ADC 24 [11]
GRM payload C1
Undisclosed
Val-Gln linker
38283215 ADC 25 [11]
GRM payload C1
Undisclosed
Val-Glu linker
38283215 ADC 26 [11]
GRM payload C1
Undisclosed
Val-Gly linker
38283215 ADC 27 [11]
GRM payload C1
Undisclosed
Val-Ser linker
38283215 ADC 28 [11]
GRM payload C1
Undisclosed
Ala-Ala linker
38283215 ADC 29 [11]
GRM payload C1
Undisclosed
Ala-Arg linker
38283215 ADC 30 [11]
GRM payload C1
Undisclosed
Ala-Gln linker
38283215 ADC 31 [11]
GRM payload C1
Undisclosed
Ala-Glu linker
38283215 ADC 32 [11]
GRM payload C1
Undisclosed
Ala-Gly linker
38283215 ADC 33 [11]
GRM payload C1
Undisclosed
Ala-His linker
38283215 ADC 34 [11]
GRM payload C1
Undisclosed
Ala-Ser linker
38283215 ADC 35 [11]
GRM payload C1
Undisclosed
Ala-Asn linker
38283215 ADC 36 [11]
GRM payload C1
Undisclosed
Ala-Val linker
38283215 ADC 37 [11]
GRM payload C1
Undisclosed
Ala-Phe linker
38283215 ADC 38 [11]
GRM payload C1
Undisclosed
Gly-Ala linker
38283215 ADC 39 [11]
GRM payload C1
Undisclosed
Gly-Gln linker
38283215 ADC 40 [11]
GRM payload C1
Undisclosed
Gly-Glu linker
38283215 ADC 41 [11]
GRM payload C1
Undisclosed
Gly-Gly linker
38283215 ADC 42 [11]
GRM payload C1
Undisclosed
Gly-Ser linker
38283215 ADC 43 [11]
GRM payload C1
Undisclosed
Phe-Lys linker
38283215 ADC 44 [11]
GRM payload C1
Undisclosed
Ser-Ala linker
38283215 ADC 45 [11]
GRM payload C1
Undisclosed
Ser-Asn linker
38283215 ADC 46 [11]
GRM payload C1
Undisclosed
Ser-Gln linker
38283215 ADC 47 [11]
GRM payload C1
Undisclosed
Ser-Glu linker
38283215 ADC 48 [11]
GRM payload C1
Undisclosed
Ser-Gly linker
38283215 ADC 49 [11]
GRM payload C1
Undisclosed
Val-Ala linker
38283215 ADC 50 [11]
GRM payload C1
Undisclosed
Val-Arg linker
38283215 ADC 51 [11]
GRM payload C1
Undisclosed
Val-Cit linker
38283215 ADC 52 [11]
GRM payload C1
Undisclosed
Val-Asn linker
38283215 ADC 53 [11]
GRM payload C1
Undisclosed
Val-Gln linker
38283215 ADC 54 [11]
GRM payload C1
Undisclosed
Val-Glu linker
38283215 ADC 55 [11]
GRM payload C1
Undisclosed
Val-Gly linker
38283215 ADC 56 [11]
GRM payload C1
Undisclosed
Val-Ser linker
References
Ref 1 Zyngenia biotherapeutics company program bi-specific anti-TNFalpha/Ang2 Zybodies.
Ref 2 Introduction to basic information on ADC drug adalimumab fosimdesonide.
Ref 3 Steroid conjugate; 2022-08-18.
Ref 4 Steroid compound and conjugate thereof; 2023-03-02.
Ref 5 Steroid conjugate; 2022-06-30.
Ref 6 Covalent linkers in antibody-drug conjugates and methods of making and using the same.
Ref 7 ValCitGlyPro-dexamethasone antibody conjugates selectively suppress the activation of human monocytes
Ref 8 Anti-TNF Thioester Glucocorticoid Antibody-Drug Conjugate Fully Inhibits Inflammation with Minimal Effect on Systemic Corticosterone Levels in a Mouse Arthritis Model
Ref 9 Optimization of Drug-Linker to Enable Long-term Storage of Antibody-Drug Conjugate for Subcutaneous Dosing
Ref 10 Use of hydroxypropyl-β-cyclodextrin in stabilizing antibody-drug conjugate formulations
Ref 11 Impact of dipeptide on ADC physicochemical properties and efficacy identifies Ala-Ala as the optimal dipeptide